Groundbreaking research reveals how gut microbes and dietary soy can influence the outcome of cancer treatments, paving the way for a new frontier in personalized oncology. Study: Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors. Image Credit: CI Photos / Shutterstock In a recent study published in the journal Cell, researchers demonstrated that phytochemicals … Read more
An immunotherapy drug could help some cancer patients live years longer without the disease getting worse or coming back, a trial has found. Pembrolizumab, sold under the brand name Keytruda, kept head and neck cancers at bay for five years compared to 30 months with standard care. It also slashed the risk of the disease … Read more
The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, Cancer Treatment and Survivorship Statistics, 2025, led by the American Cancer Society (ACS). The study also found notable … Read more
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from UCL and the Institute of Cancer Research. The researchers analyzed prostate cancer tumour samples from men with high-risk prostate cancer that had not spread, who took … Read more
Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. The study, published in the journal Nano Letters, explores a way to make high-intensity focused ultrasound less harmful to healthy tissues. Oregon Health & Science University was the first hospital in Oregon to offer … Read more
Revolutionizing Soft Tissue Sarcoma Treatment with Functional Precision Medicine Soft tissue sarcomas (STS) represent a formidable challenge in oncology. A recent collaborative study involving leading research institutions and a biotech firm has unveiled a promising new strategy for improving treatment outcomes for these rare and aggressive cancers. The findings, published in npj Precision Oncology, highlight … Read more
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes RNA molecules in the bloodstream. This type of RNA is called cell-free RNA because the tiny molecules no longer inhabit a cell. There are always fragments of … Read more
Roswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy. The little known, but highly promising technology breakthrough makes it possible for your body to fight cancer, often without invasive surgery, offering patients new hope for the possibility of long-term remission. However, a new survey … Read more
Announcing a new article publication for the BIO Integration journal. Lipid-based Nanoparticles (LBNPs) have emerged as a transformative approach in cancer treatment, offering innovative drug delivery solutions that enhance therapeutic efficacy while minimizing adverse effects. This study highlights how LBNPs have been used to overcome the limitations of traditional chemotherapy and improve patient outcomes by exploring … Read more
Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors – a smart fighter that destroys cancer cells for days without tiring. USC biomedical engineers have made this concept a reality, crafting what they have named the “EchoBack CAR T-cell,” which could soon be a game changer in the field … Read more